Global Intravitreal Injectable Market Growth (Status and Outlook) 2025-2031

August 2025 | 94 pages | ID: G98BEEF9BAFDEN
LP Information

Abstracts

According to this study, the global Intravitreal Injectable market size will reach US$ 28490 million by 2031.

Intravitreal injectables are sterile pharmaceutical formulations administered directly into the vitreous humor of the eye using a fine needle. This route of administration allows for targeted delivery of medications—such as anti-VEGF agents, corticosteroids, or antibiotics—into the posterior segment of the eye, ensuring high local drug concentrations while minimizing systemic exposure. Intravitreal injections are commonly used to treat retinal diseases including age-related macular degeneration (AMD), diabetic macular edema (DME), retinal vein occlusion (RVO), and infectious endophthalmitis.

The global intravitreal injectable market has experienced steady growth in recent years, driven primarily by the rising prevalence of retinal disorders such as macular edema, age-related macular degeneration (AMD), and retinal vein occlusion (RVO). Leading pharmaceutical players in this space include Regeneron Pharmaceuticals (notably with Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, and Kanghong Pharmaceutical. These top five companies collectively account for over 70% of global market share, reflecting a relatively concentrated competitive landscape. North America currently dominates the global market, holding a share of more than 50%, followed by Europe and Asia-Pacific, each with shares exceeding 40%.

In terms of drug types, anti-VEGF (vascular endothelial growth factor) therapies represent the largest and most significant market segment, contributing to over 85% of total market revenue. These agents are highly effective in inhibiting abnormal blood vessel growth in the retina, making them the standard of care for diseases like AMD and diabetic macular edema (DME). Other therapeutic classes such as corticosteroids and antibiotics play smaller roles, typically in more specialized or adjunctive treatment scenarios.

The largest clinical application of intravitreal injectables is for macular edema, which continues to see a rise in incidence linked to diabetes and aging populations worldwide. Macular degeneration and RVO are also major contributors to demand, reinforcing the importance of targeted ophthalmic treatments. The increase in awareness, earlier diagnosis, and improved accessibility to eye care services are further driving market expansion across both developed and emerging regions.

Looking ahead, the market is expected to grow steadily due to increasing disease burden and product innovation. Notably, new players such as Astellas Pharma have begun entering the market, signaling a shift toward broader competition and possibly next-generation therapies with extended efficacy and dosing intervals. Advances in drug delivery systems, longer-acting formulations, and biosimilars are expected to further shape the landscape and offer new growth opportunities.

LPI (LP Information)' newest research report, the “Intravitreal Injectable Industry Forecast” looks at past sales and reviews total world Intravitreal Injectable sales in 2024, providing a comprehensive analysis by region and market sector of projected Intravitreal Injectable sales for 2025 through 2031. With Intravitreal Injectable sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravitreal Injectable industry.

This Insight Report provides a comprehensive analysis of the global Intravitreal Injectable landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Intravitreal Injectable portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intravitreal Injectable market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravitreal Injectable and breaks down the forecast by Drug, by Disease, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravitreal Injectable.

This report presents a comprehensive overview, market shares, and growth opportunities of Intravitreal Injectable market by product type, application, key players and key regions and countries.

Segmentation by Drug:

• Anti-VEGF
• Steroids
• Others

Segmentation by Disease:

• Macular Degeneration
• Macular Edema
• Uveitis
• Retinal Vein Occlusion
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Regeneron Pharmaceuticals (Eylea)
• Allergan
• EyePoint Pharmaceuticals
• Genentech
• Kanghong Pharmaceutical
• Astellas Pharma
• Clearside Biomedical
• Bayer

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Intravitreal Injectable Market Size (2020-2031)
  2.1.2 Intravitreal Injectable Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Intravitreal Injectable by Country/Region (2020, 2024 & 2031)
2.2 Intravitreal Injectable Segment by Drug
  2.2.1 Anti-VEGF
  2.2.2 Steroids
  2.2.3 Others
2.3 Intravitreal Injectable Market Size by Drug
  2.3.1 Intravitreal Injectable Market Size CAGR by Drug (2020 VS 2024 VS 2031)
  2.3.2 Global Intravitreal Injectable Market Size Market Share by Drug (2020-2025)
2.4 Intravitreal Injectable Segment by Disease
  2.4.1 Macular Degeneration
  2.4.2 Macular Edema
  2.4.3 Uveitis
  2.4.4 Retinal Vein Occlusion
  2.4.5 Others
2.5 Intravitreal Injectable Market Size by Disease
  2.5.1 Intravitreal Injectable Market Size CAGR by Disease (2020 VS 2024 VS 2031)
  2.5.2 Global Intravitreal Injectable Market Size Market Share by Disease (2020-2025)

3 INTRAVITREAL INJECTABLE MARKET SIZE BY PLAYER

3.1 Intravitreal Injectable Market Size Market Share by Player
  3.1.1 Global Intravitreal Injectable Revenue by Player (2020-2025)
  3.1.2 Global Intravitreal Injectable Revenue Market Share by Player (2020-2025)
3.2 Global Intravitreal Injectable Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 INTRAVITREAL INJECTABLE BY REGION

4.1 Intravitreal Injectable Market Size by Region (2020-2025)
4.2 Global Intravitreal Injectable Annual Revenue by Country/Region (2020-2025)
4.3 Americas Intravitreal Injectable Market Size Growth (2020-2025)
4.4 APAC Intravitreal Injectable Market Size Growth (2020-2025)
4.5 Europe Intravitreal Injectable Market Size Growth (2020-2025)
4.6 Middle East & Africa Intravitreal Injectable Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Intravitreal Injectable Market Size by Country (2020-2025)
5.2 Americas Intravitreal Injectable Market Size by Drug (2020-2025)
5.3 Americas Intravitreal Injectable Market Size by Disease (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Intravitreal Injectable Market Size by Region (2020-2025)
6.2 APAC Intravitreal Injectable Market Size by Drug (2020-2025)
6.3 APAC Intravitreal Injectable Market Size by Disease (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Intravitreal Injectable Market Size by Country (2020-2025)
7.2 Europe Intravitreal Injectable Market Size by Drug (2020-2025)
7.3 Europe Intravitreal Injectable Market Size by Disease (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Intravitreal Injectable by Region (2020-2025)
8.2 Middle East & Africa Intravitreal Injectable Market Size by Drug (2020-2025)
8.3 Middle East & Africa Intravitreal Injectable Market Size by Disease (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL INTRAVITREAL INJECTABLE MARKET FORECAST

10.1 Global Intravitreal Injectable Forecast by Region (2026-2031)
  10.1.1 Global Intravitreal Injectable Forecast by Region (2026-2031)
  10.1.2 Americas Intravitreal Injectable Forecast
  10.1.3 APAC Intravitreal Injectable Forecast
  10.1.4 Europe Intravitreal Injectable Forecast
  10.1.5 Middle East & Africa Intravitreal Injectable Forecast
10.2 Americas Intravitreal Injectable Forecast by Country (2026-2031)
  10.2.1 United States Market Intravitreal Injectable Forecast
  10.2.2 Canada Market Intravitreal Injectable Forecast
  10.2.3 Mexico Market Intravitreal Injectable Forecast
  10.2.4 Brazil Market Intravitreal Injectable Forecast
10.3 APAC Intravitreal Injectable Forecast by Region (2026-2031)
  10.3.1 China Intravitreal Injectable Market Forecast
  10.3.2 Japan Market Intravitreal Injectable Forecast
  10.3.3 Korea Market Intravitreal Injectable Forecast
  10.3.4 Southeast Asia Market Intravitreal Injectable Forecast
  10.3.5 India Market Intravitreal Injectable Forecast
  10.3.6 Australia Market Intravitreal Injectable Forecast
10.4 Europe Intravitreal Injectable Forecast by Country (2026-2031)
  10.4.1 Germany Market Intravitreal Injectable Forecast
  10.4.2 France Market Intravitreal Injectable Forecast
  10.4.3 UK Market Intravitreal Injectable Forecast
  10.4.4 Italy Market Intravitreal Injectable Forecast
  10.4.5 Russia Market Intravitreal Injectable Forecast
10.5 Middle East & Africa Intravitreal Injectable Forecast by Region (2026-2031)
  10.5.1 Egypt Market Intravitreal Injectable Forecast
  10.5.2 South Africa Market Intravitreal Injectable Forecast
  10.5.3 Israel Market Intravitreal Injectable Forecast
  10.5.4 Turkey Market Intravitreal Injectable Forecast
10.6 Global Intravitreal Injectable Forecast by Drug (2026-2031)
10.7 Global Intravitreal Injectable Forecast by Disease (2026-2031)
  10.7.1 GCC Countries Market Intravitreal Injectable Forecast

11 KEY PLAYERS ANALYSIS

11.1 Regeneron Pharmaceuticals (Eylea)
  11.1.1 Regeneron Pharmaceuticals (Eylea) Company Information
  11.1.2 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Offered
  11.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Regeneron Pharmaceuticals (Eylea) Main Business Overview
  11.1.5 Regeneron Pharmaceuticals (Eylea) Latest Developments
11.2 Allergan
  11.2.1 Allergan Company Information
  11.2.2 Allergan Intravitreal Injectable Product Offered
  11.2.3 Allergan Intravitreal Injectable Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Allergan Main Business Overview
  11.2.5 Allergan Latest Developments
11.3 EyePoint Pharmaceuticals
  11.3.1 EyePoint Pharmaceuticals Company Information
  11.3.2 EyePoint Pharmaceuticals Intravitreal Injectable Product Offered
  11.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 EyePoint Pharmaceuticals Main Business Overview
  11.3.5 EyePoint Pharmaceuticals Latest Developments
11.4 Genentech
  11.4.1 Genentech Company Information
  11.4.2 Genentech Intravitreal Injectable Product Offered
  11.4.3 Genentech Intravitreal Injectable Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Genentech Main Business Overview
  11.4.5 Genentech Latest Developments
11.5 Kanghong Pharmaceutical
  11.5.1 Kanghong Pharmaceutical Company Information
  11.5.2 Kanghong Pharmaceutical Intravitreal Injectable Product Offered
  11.5.3 Kanghong Pharmaceutical Intravitreal Injectable Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Kanghong Pharmaceutical Main Business Overview
  11.5.5 Kanghong Pharmaceutical Latest Developments
11.6 Astellas Pharma
  11.6.1 Astellas Pharma Company Information
  11.6.2 Astellas Pharma Intravitreal Injectable Product Offered
  11.6.3 Astellas Pharma Intravitreal Injectable Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Astellas Pharma Main Business Overview
  11.6.5 Astellas Pharma Latest Developments
11.7 Clearside Biomedical
  11.7.1 Clearside Biomedical Company Information
  11.7.2 Clearside Biomedical Intravitreal Injectable Product Offered
  11.7.3 Clearside Biomedical Intravitreal Injectable Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Clearside Biomedical Main Business Overview
  11.7.5 Clearside Biomedical Latest Developments
11.8 Bayer
  11.8.1 Bayer Company Information
  11.8.2 Bayer Intravitreal Injectable Product Offered
  11.8.3 Bayer Intravitreal Injectable Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Bayer Main Business Overview
  11.8.5 Bayer Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Intravitreal Injectable Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Intravitreal Injectable Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Anti-VEGF
Table 4. Major Players of Steroids
Table 5. Major Players of Others
Table 6. Intravitreal Injectable Market Size CAGR by Drug (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Intravitreal Injectable Market Size by Drug (2020-2025) & ($ millions)
Table 8. Global Intravitreal Injectable Market Size Market Share by Drug (2020-2025)
Table 9. Intravitreal Injectable Market Size CAGR by Disease (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Intravitreal Injectable Market Size by Disease (2020-2025) & ($ millions)
Table 11. Global Intravitreal Injectable Market Size Market Share by Disease (2020-2025)
Table 12. Global Intravitreal Injectable Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Intravitreal Injectable Revenue Market Share by Player (2020-2025)
Table 14. Intravitreal Injectable Key Players Head office and Products Offered
Table 15. Intravitreal Injectable Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Intravitreal Injectable Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Intravitreal Injectable Market Size Market Share by Region (2020-2025)
Table 20. Global Intravitreal Injectable Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Intravitreal Injectable Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Intravitreal Injectable Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Intravitreal Injectable Market Size Market Share by Country (2020-2025)
Table 24. Americas Intravitreal Injectable Market Size by Drug (2020-2025) & ($ millions)
Table 25. Americas Intravitreal Injectable Market Size Market Share by Drug (2020-2025)
Table 26. Americas Intravitreal Injectable Market Size by Disease (2020-2025) & ($ millions)
Table 27. Americas Intravitreal Injectable Market Size Market Share by Disease (2020-2025)
Table 28. APAC Intravitreal Injectable Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Intravitreal Injectable Market Size Market Share by Region (2020-2025)
Table 30. APAC Intravitreal Injectable Market Size by Drug (2020-2025) & ($ millions)
Table 31. APAC Intravitreal Injectable Market Size by Disease (2020-2025) & ($ millions)
Table 32. Europe Intravitreal Injectable Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Intravitreal Injectable Market Size Market Share by Country (2020-2025)
Table 34. Europe Intravitreal Injectable Market Size by Drug (2020-2025) & ($ millions)
Table 35. Europe Intravitreal Injectable Market Size by Disease (2020-2025) & ($ millions)
Table 36. Middle East & Africa Intravitreal Injectable Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Intravitreal Injectable Market Size by Drug (2020-2025) & ($ millions)
Table 38. Middle East & Africa Intravitreal Injectable Market Size by Disease (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Intravitreal Injectable
Table 40. Key Market Challenges & Risks of Intravitreal Injectable
Table 41. Key Industry Trends of Intravitreal Injectable
Table 42. Global Intravitreal Injectable Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Intravitreal Injectable Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Intravitreal Injectable Market Size Forecast by Drug (2026-2031) & ($ millions)
Table 45. Global Intravitreal Injectable Market Size Forecast by Disease (2026-2031) & ($ millions)
Table 46. Regeneron Pharmaceuticals (Eylea) Details, Company Type, Intravitreal Injectable Area Served and Its Competitors
Table 47. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Offered
Table 48. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Regeneron Pharmaceuticals (Eylea) Main Business
Table 50. Regeneron Pharmaceuticals (Eylea) Latest Developments
Table 51. Allergan Details, Company Type, Intravitreal Injectable Area Served and Its Competitors
Table 52. Allergan Intravitreal Injectable Product Offered
Table 53. Allergan Intravitreal Injectable Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Allergan Main Business
Table 55. Allergan Latest Developments
Table 56. EyePoint Pharmaceuticals Details, Company Type, Intravitreal Injectable Area Served and Its Competitors
Table 57. EyePoint Pharmaceuticals Intravitreal Injectable Product Offered
Table 58. EyePoint Pharmaceuticals Intravitreal Injectable Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. EyePoint Pharmaceuticals Main Business
Table 60. EyePoint Pharmaceuticals Latest Developments
Table 61. Genentech Details, Company Type, Intravitreal Injectable Area Served and Its Competitors
Table 62. Genentech Intravitreal Injectable Product Offered
Table 63. Genentech Intravitreal Injectable Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Genentech Main Business
Table 65. Genentech Latest Developments
Table 66. Kanghong Pharmaceutical Details, Company Type, Intravitreal Injectable Area Served and Its Competitors
Table 67. Kanghong Pharmaceutical Intravitreal Injectable Product Offered
Table 68. Kanghong Pharmaceutical Intravitreal Injectable Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Kanghong Pharmaceutical Main Business
Table 70. Kanghong Pharmaceutical Latest Developments
Table 71. Astellas Pharma Details, Company Type, Intravitreal Injectable Area Served and Its Competitors
Table 72. Astellas Pharma Intravitreal Injectable Product Offered
Table 73. Astellas Pharma Intravitreal Injectable Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Astellas Pharma Main Business
Table 75. Astellas Pharma Latest Developments
Table 76. Clearside Biomedical Details, Company Type, Intravitreal Injectable Area Served and Its Competitors
Table 77. Clearside Biomedical Intravitreal Injectable Product Offered
Table 78. Clearside Biomedical Intravitreal Injectable Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Clearside Biomedical Main Business
Table 80. Clearside Biomedical Latest Developments
Table 81. Bayer Details, Company Type, Intravitreal Injectable Area Served and Its Competitors
Table 82. Bayer Intravitreal Injectable Product Offered
Table 83. Bayer Intravitreal Injectable Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Bayer Main Business
Table 85. Bayer Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Intravitreal Injectable Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Intravitreal Injectable Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Intravitreal Injectable Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Intravitreal Injectable Sales Market Share by Country/Region (2024)
Figure 8. Intravitreal Injectable Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Intravitreal Injectable Market Size Market Share by Drug in 2024
Figure 10. Intravitreal Injectable in Macular Degeneration
Figure 11. Global Intravitreal Injectable Market: Macular Degeneration (2020-2025) & ($ millions)
Figure 12. Intravitreal Injectable in Macular Edema
Figure 13. Global Intravitreal Injectable Market: Macular Edema (2020-2025) & ($ millions)
Figure 14. Intravitreal Injectable in Uveitis
Figure 15. Global Intravitreal Injectable Market: Uveitis (2020-2025) & ($ millions)
Figure 16. Intravitreal Injectable in Retinal Vein Occlusion
Figure 17. Global Intravitreal Injectable Market: Retinal Vein Occlusion (2020-2025) & ($ millions)
Figure 18. Intravitreal Injectable in Others
Figure 19. Global Intravitreal Injectable Market: Others (2020-2025) & ($ millions)
Figure 20. Global Intravitreal Injectable Market Size Market Share by Disease in 2024
Figure 21. Global Intravitreal Injectable Revenue Market Share by Player in 2024
Figure 22. Global Intravitreal Injectable Market Size Market Share by Region (2020-2025)
Figure 23. Americas Intravitreal Injectable Market Size 2020-2025 ($ millions)
Figure 24. APAC Intravitreal Injectable Market Size 2020-2025 ($ millions)
Figure 25. Europe Intravitreal Injectable Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Intravitreal Injectable Market Size 2020-2025 ($ millions)
Figure 27. Americas Intravitreal Injectable Value Market Share by Country in 2024
Figure 28. United States Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Intravitreal Injectable Market Size Market Share by Region in 2024
Figure 33. APAC Intravitreal Injectable Market Size Market Share by Drug (2020-2025)
Figure 34. APAC Intravitreal Injectable Market Size Market Share by Disease (2020-2025)
Figure 35. China Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 39. India Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Intravitreal Injectable Market Size Market Share by Country in 2024
Figure 42. Europe Intravitreal Injectable Market Size Market Share by Drug (2020-2025)
Figure 43. Europe Intravitreal Injectable Market Size Market Share by Disease (2020-2025)
Figure 44. Germany Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 45. France Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Intravitreal Injectable Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Intravitreal Injectable Market Size Market Share by Drug (2020-2025)
Figure 51. Middle East & Africa Intravitreal Injectable Market Size Market Share by Disease (2020-2025)
Figure 52. Egypt Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Intravitreal Injectable Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 58. APAC Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 59. Europe Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 61. United States Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 62. Canada Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 63. Mexico Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 64. Brazil Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 65. China Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 66. Japan Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 67. Korea Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 69. India Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 70. Australia Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 71. Germany Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 72. France Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 73. UK Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 74. Italy Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 75. Russia Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 76. Egypt Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 77. South Africa Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 78. Israel Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 79. Turkey Intravitreal Injectable Market Size 2026-2031 ($ millions)
Figure 80. Global Intravitreal Injectable Market Size Market Share Forecast by Drug (2026-2031)
Figure 81. Global Intravitreal Injectable Market Size Market Share Forecast by Disease (2026-2031)
Figure 82. GCC Countries Intravitreal Injectable Market Size 2026-2031 ($ millions)